Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Gliclazide"" wg kryterium: Temat

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 1731
Tytuł:
Polydimethylsiloxane Organic-Inorganic Composite Drug Reservoir with Gliclazide.
Autorzy:
Gedawy A; Curtin Medical School, Curtin University, Bentley 6102, Australia.; Curtin Health Innovation Research Institute, Curtin University, Bentley 6102, Australia.
Al-Salami H; Curtin Medical School, Curtin University, Bentley 6102, Australia.; Curtin Health Innovation Research Institute, Curtin University, Bentley 6102, Australia.
Dass CR; Curtin Medical School, Curtin University, Bentley 6102, Australia.; Curtin Health Innovation Research Institute, Curtin University, Bentley 6102, Australia.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2024 Apr 03; Vol. 25 (7). Date of Electronic Publication: 2024 Apr 03.
Typ publikacji:
Journal Article
MeSH Terms:
Gliclazide*/pharmacology
Dimethylpolysiloxanes ; Alginates ; Biocompatible Materials
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Antidiabetic drug administration prevents bone mineral density loss: Evidence from a two-sample Mendelian randomization study.
Autorzy:
Chen M; School of Pharmacy, Quanzhou Medical College, Quanzhou, China.
Lin S; School of Pharmacy, Quanzhou Medical College, Quanzhou, China.
Chen W; School of Pharmacy, Quanzhou Medical College, Quanzhou, China.
Chen X; Department of Orthopaedic Surgery, Quanzhou First Hospital Affiliated to Fujian Medical University, Quanzhou, China.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2024 Mar 07; Vol. 19 (3), pp. e0300009. Date of Electronic Publication: 2024 Mar 07 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
Diabetes Mellitus*
Gliclazide*/pharmacology
Gliclazide*/therapeutic use
Metformin*/pharmacology
Metformin*/therapeutic use
Humans ; Bone Density/genetics ; Genome-Wide Association Study ; Hypoglycemic Agents/pharmacology ; Hypoglycemic Agents/therapeutic use ; Insulin ; Insulin, Regular, Human ; Mendelian Randomization Analysis ; Polymorphism, Single Nucleotide ; Reproducibility of Results ; Rosiglitazone
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Anti-inflammation-based treatment of atherosclerosis using Gliclazide-loaded biomimetic nanoghosts.
Autorzy:
Karami Z; Department of Microbiology and Immunology, Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran.
Mehrzad J; Department of Microbiology and Immunology, Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran. .
Akrami M; Department of Pharmaceutical Biomaterials and Medical Biomaterials Research Center, Faculty of Pharmacy, Tehran University of Medical Sciences, and Institute of Biomaterials, University of Tehran and Tehran University of Medical Sciences (IBUTUMS), Tehran, Iran. .
Hosseinkhani S; Department of Biochemistry, Faculty of Biological Sciences, Tarbiat Modares University, Tehran, Iran.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2023 Aug 24; Vol. 13 (1), pp. 13880. Date of Electronic Publication: 2023 Aug 24.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Gliclazide*
Atherosclerosis*/drug therapy
Plaque, Atherosclerotic*/drug therapy
Lagomorpha*
Animals ; Rabbits ; Biomimetics ; Anti-Inflammatory Agents/pharmacology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Gliclazide disposition in overdose - a case report with pharmacokinetic modeling.
Autorzy:
Mégarbane B; Department of Medical and Toxicological Critical Care, Lariboisière Hospital, Federation of Toxicology, APHP, Paris, France.; Paris University, Paris, France.
Chevillard L; Paris University, Paris, France.
Khoudour N; Laboratory of Pharmacology and Toxicology, Cochin Hospital, APHP, Paris, France.
Declèves X; Paris University, Paris, France.; Laboratory of Pharmacology and Toxicology, Cochin Hospital, APHP, Paris, France.
Pokaż więcej
Źródło:
Clinical toxicology (Philadelphia, Pa.) [Clin Toxicol (Phila)] 2022 Apr; Vol. 60 (4), pp. 541-542. Date of Electronic Publication: 2021 Oct 26.
Typ publikacji:
Case Reports; Letter
MeSH Terms:
Drug Overdose*
Gliclazide*/pharmacokinetics
Blood Glucose ; Humans ; Hypoglycemic Agents
Raport
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
In Vitro Investigation of Binding Interactions between Albumin-Gliclazide Model and Typical Hypotensive Drugs.
Autorzy:
Zurawska-Plaksej E; Department of Toxicology, Wroclaw Medical University, 50-556 Wroclaw, Poland.
Wiglusz R; Institute of Low Temperature and Structure Research, Polish Academy of Sciences, 50-422 Wroclaw, Poland.
Piwowar A; Department of Toxicology, Wroclaw Medical University, 50-556 Wroclaw, Poland.
Wiglusz K; Department of Analytical Chemistry, Wroclaw Medical University, 50-556 Wroclaw, Poland.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2021 Dec 28; Vol. 23 (1). Date of Electronic Publication: 2021 Dec 28.
Typ publikacji:
Journal Article
MeSH Terms:
Models, Biological*
Albumins/*metabolism
Antihypertensive Agents/*pharmacology
Gliclazide/*pharmacology
Animals ; Antihypertensive Agents/chemistry ; Cattle ; Circular Dichroism ; Fluorescence ; Gliclazide/chemistry ; Kinetics ; Ligands ; Protein Binding/drug effects ; Protein Structure, Secondary ; Serum Albumin, Bovine/chemistry
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Alleviation of cisplatin-induced hepatotoxicity by gliclazide: Involvement of oxidative stress and caspase-3 activity.
Autorzy:
Taghizadeh F; Department of Anatomy, Faculty of Medicine, Molecular and Cell Biology Research Center, Mazandaran University of Medical Sciences, Sari, Iran.; Student Research Committee, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.
Hosseinimehr SJ; Department of Radiopharmacy, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran.
Zargari M; Department of Biochemistry, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.
Karimpour Malekshah A; Department of Anatomy, Faculty of Medicine, Molecular and Cell Biology Research Center, Mazandaran University of Medical Sciences, Sari, Iran.
Mirzaei M; Department of Anatomy, Faculty of Medicine, Molecular and Cell Biology Research Center, Mazandaran University of Medical Sciences, Sari, Iran.
Talebpour Amiri F; Department of Anatomy, Faculty of Medicine, Molecular and Cell Biology Research Center, Mazandaran University of Medical Sciences, Sari, Iran.
Pokaż więcej
Źródło:
Pharmacology research & perspectives [Pharmacol Res Perspect] 2021 May; Vol. 9 (3), pp. e00788.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Anti-Inflammatory Agents/*therapeutic use
Antineoplastic Agents/*toxicity
Antioxidants/*therapeutic use
Chemical and Drug Induced Liver Injury/*drug therapy
Cisplatin/*toxicity
Gliclazide/*therapeutic use
Alanine Transaminase/blood ; Alkaline Phosphatase/blood ; Animals ; Anti-Inflammatory Agents/pharmacology ; Antioxidants/pharmacology ; Apoptosis/drug effects ; Aspartate Aminotransferases/blood ; Caspase 3/metabolism ; Chemical and Drug Induced Liver Injury/blood ; Chemical and Drug Induced Liver Injury/metabolism ; Chemical and Drug Induced Liver Injury/pathology ; Gliclazide/pharmacology ; Glutathione/metabolism ; Liver/drug effects ; Liver/metabolism ; Liver/pathology ; Male ; Malondialdehyde/metabolism ; Mice, Inbred BALB C ; Oxidative Stress/drug effects ; Mice
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Mucoadhesive microspheres of glutaraldehyde crosslinked mucilage of Isabgol husk for sustained release of gliclazide.
Autorzy:
Sharma VK; Department of Pharmaceutical Sciences, Gurukul Kangri (Deemed to be University), Haridwar, Uttarakhand, India.
Sharma PP; Department of Pharmaceutical Sciences, Gurukul Kangri (Deemed to be University), Haridwar, Uttarakhand, India.
Mazumder B; Department of Pharmaceutical Sciences, Dibrugarh University, Dibrugarh, India.
Bhatnagar A; Department of Nuclear Medicine, Institute of Nuclear Medicine and Allied Sciences, Delhi, India.
Subramaniyan V; Faculty of Medicine, Bioscience and Nursing, MAHSA University, Kuala Lumpur, Malaysia.
Fuloria S; Faculty of Pharmacy, AIMST University, Kedah, Malaysia.
Fuloria NK; Faculty of Pharmacy, AIMST University, Kedah, Malaysia.
Pokaż więcej
Źródło:
Journal of biomaterials science. Polymer edition [J Biomater Sci Polym Ed] 2021 Aug; Vol. 32 (11), pp. 1420-1449. Date of Electronic Publication: 2021 May 30.
Typ publikacji:
Journal Article
MeSH Terms:
Gliclazide*
Animals ; Delayed-Action Preparations ; Drug Delivery Systems ; Glutaral ; Microspheres ; Particle Size ; Rabbits
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Simultaneous HPLC Assay of Gliclazide and Ciprofloxacin in Plasma and its Implementation for Pharmacokinetic Study in Rats.
Autorzy:
Sasongko L; Department of Pharmaceutics, School of Pharmacy, Institut Teknologi Bandung, Bandung 40132, Indonesia.
Pratiwi GK; Department of Pharmaceutics, School of Pharmacy, Institut Teknologi Bandung, Bandung 40132, Indonesia.
Leo M; Department of Pharmaceutics, School of Pharmacy, Institut Teknologi Bandung, Bandung 40132, Indonesia.
Adiwidjaja J; Department of Pharmaceutics, School of Pharmacy, Institut Teknologi Bandung, Bandung 40132, Indonesia.; Sydney Pharmacy School, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW 2006, Australia.
Pokaż więcej
Źródło:
Journal of chromatographic science [J Chromatogr Sci] 2021 Mar 19; Vol. 59 (4), pp. 338-346.
Typ publikacji:
Journal Article
MeSH Terms:
Chromatography, High Pressure Liquid/*methods
Ciprofloxacin/*blood
Ciprofloxacin/*pharmacokinetics
Gliclazide/*blood
Gliclazide/*pharmacokinetics
Animals ; Ciprofloxacin/chemistry ; Drug Stability ; Gliclazide/chemistry ; Linear Models ; Male ; Rats ; Rats, Wistar ; Reproducibility of Results ; Sensitivity and Specificity
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Dual-drug amorphous formulation of gliclazide.
Autorzy:
Aljohani M; School of Chemistry, National University of Ireland, Galway, Ireland.
McArdle P; School of Chemistry, National University of Ireland, Galway, Ireland.
Erxleben A; School of Chemistry, National University of Ireland, Galway, Ireland.; Synthesis and Solid State Pharmaceutical Centre (SSPC), Limerick, Ireland.
Pokaż więcej
Źródło:
Drug development and industrial pharmacy [Drug Dev Ind Pharm] 2021 Feb; Vol. 47 (2), pp. 302-307. Date of Electronic Publication: 2021 Feb 01.
Typ publikacji:
Journal Article
MeSH Terms:
Gliclazide*
Valsartan/*chemistry
Drug Stability ; Excipients ; Solubility ; Valsartan/pharmacology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Visualized analysis and evaluation of simultaneous controlled release of metformin hydrochloride and gliclazide from sandwiched osmotic pump capsule.
Autorzy:
Gao S; Key Laboratory of Xin'an Medicine, Ministry of Education, Anhui University of Chinese Medicine, Hefei, Anhui, China.
Chen Y; Key Laboratory of Xin'an Medicine, Ministry of Education, Anhui University of Chinese Medicine, Hefei, Anhui, China.; College of Biotechnology and Pharmaceutical Engineering, West Anhui University, Lu'an, Anhui, China.
Hu R; Key Laboratory of Xin'an Medicine, Ministry of Education, Anhui University of Chinese Medicine, Hefei, Anhui, China.; Anhui Province Key Laboratory of Chinese Medicinal Formula, Anhui University of Chinese Medicine, Hefei, Anhui, China.; Anhui Province Key Laboratory of Research and Development of Chinese Medicine, Anhui University of Chinese Medicine, Hefei, Anhui, China.; Anhui Province Key Laboratory of Pharmaceutical Technology and Application, Anhui University of Chinese Medicine, Hefei, Anhui, China.
Lu W; School of Pharmacy, China Pharmaceutical University, Nanjing, Jiangsu, China.
Yu L; Key Laboratory of Xin'an Medicine, Ministry of Education, Anhui University of Chinese Medicine, Hefei, Anhui, China.
Chen J; Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St. John's University, New York, NY, USA.
Liu S; Anhui Huangshan Capsule Co., Ltd, Huangshan, Anhui, China.
Guo Y; Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St. John's University, New York, NY, USA.
Shen Q; Key Laboratory of Xin'an Medicine, Ministry of Education, Anhui University of Chinese Medicine, Hefei, Anhui, China.
Wang B; Key Laboratory of Xin'an Medicine, Ministry of Education, Anhui University of Chinese Medicine, Hefei, Anhui, China.
Fang W; Key Laboratory of Xin'an Medicine, Ministry of Education, Anhui University of Chinese Medicine, Hefei, Anhui, China.
Pokaż więcej
Źródło:
Drug development and industrial pharmacy [Drug Dev Ind Pharm] 2020 Nov; Vol. 46 (11), pp. 1776-1786. Date of Electronic Publication: 2020 Oct 12.
Typ publikacji:
Journal Article
MeSH Terms:
Diabetes Mellitus, Type 2*
Gliclazide*
Metformin*
Animals ; Delayed-Action Preparations ; Dogs ; Drug Delivery Systems ; Osmosis ; Solubility ; Tablets
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Fabrication of Second Generation Smarter PLGA Based Nanocrystal Carriers for Improvement of Drug Delivery and Therapeutic Efficacy of Gliclazide in Type-2 Diabetes Rat Model.
Autorzy:
Panda BP; Department of Pharmaceutical Technology, School of Pharmacy, Taylor's University, Lakeside Campus, No 1, Jalan Taylor's, 47500, Subang Jaya, Selangor, Malaysia. .
Krishnamoorthy R; Department of Pharmaceutical Technology, School of Pharmacy, Taylor's University, Lakeside Campus, No 1, Jalan Taylor's, 47500, Subang Jaya, Selangor, Malaysia.
Bhattamisra SK; Department of Life Sciences, School of Pharmacy, International Medical University, Kuala Lumpur, 57000, Malaysia. .
Shivashekaregowda NKH; School of Pharmacy, Taylor's University, Lakeside Campus, No 1, Jalan Taylor's, 47500, Subang Jaya, Selangor, Malaysia.
Seng LB; School of Medicine, Taylor's University, Lakeside Campus, No 1, Jalan Taylor's, 47500, Subang Jaya, Selangor, Malaysia.
Patnaik S; University College of Pharmaceutical Sciences, Kakatiya University, Warangal, Telangana, India.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2019 Nov 22; Vol. 9 (1), pp. 17331. Date of Electronic Publication: 2019 Nov 22.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Diabetes Mellitus, Experimental/*drug therapy
Diabetes Mellitus, Type 2/*drug therapy
Gliclazide/*administration & dosage
Hypoglycemic Agents/*administration & dosage
Polylactic Acid-Polyglycolic Acid Copolymer/*chemistry
Animals ; Biological Availability ; Delayed-Action Preparations ; Disease Models, Animal ; Gliclazide/chemistry ; Gliclazide/pharmacokinetics ; Hypoglycemic Agents/chemistry ; Hypoglycemic Agents/pharmacokinetics ; Male ; Nanoparticles/chemistry ; Niacinamide/adverse effects ; Particle Size ; Rats ; Streptozocin/adverse effects
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Incident Hepatocellular Carcinoma Risk in Patients Treated with a Sulfonylurea: A Nationwide, Nested, Case-Control Study.
Autorzy:
Lee JY; Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea.
Jang SY; Department of Preventive Medicine, Eulgi University College of Medicine, Daejeon, Republic of Korea.
Nam CM; Department of Preventive Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea. .
Kang ES; Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2019 Jun 12; Vol. 9 (1), pp. 8532. Date of Electronic Publication: 2019 Jun 12.
Typ publikacji:
Journal Article; Randomized Controlled Trial
MeSH Terms:
Carcinoma, Hepatocellular*/chemically induced
Carcinoma, Hepatocellular*/epidemiology
Diabetes Mellitus, Type 2*/drug therapy
Diabetes Mellitus, Type 2*/epidemiology
Gliclazide*/administration & dosage
Gliclazide*/adverse effects
Liver Neoplasms*/chemically induced
Liver Neoplasms*/epidemiology
Sulfonylurea Compounds*/administration & dosage
Sulfonylurea Compounds*/adverse effects
Adult ; Aged ; Aged, 80 and over ; Female ; Humans ; Incidence ; Male ; Middle Aged ; Republic of Korea/epidemiology ; Risk Factors
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Optimization of gliclazide loaded alginate-gelatin beads employing central composite design.
Autorzy:
Elsayed EW; Medicinal and Pharmaceutical Chemistry Department, Pharmaceutical and Drug Industries Research Division, National Research Centre, Giza, Egypt.
El-Ashmawy AA; Medicinal and Pharmaceutical Chemistry Department, Pharmaceutical and Drug Industries Research Division, National Research Centre, Giza, Egypt.
Mursi NM; Department of Pharmaceutics, Faculty of Pharmacy, Cairo University, Cairo, Egypt.
Emara LH; Medicinal and Pharmaceutical Chemistry Department, Pharmaceutical and Drug Industries Research Division, National Research Centre, Giza, Egypt.
Pokaż więcej
Źródło:
Drug development and industrial pharmacy [Drug Dev Ind Pharm] 2019 Dec; Vol. 45 (12), pp. 1959-1972. Date of Electronic Publication: 2019 Nov 14.
Typ publikacji:
Journal Article
MeSH Terms:
Chemistry, Pharmaceutical/*methods
Drug Carriers/*chemistry
Gliclazide/*pharmacokinetics
Alginates/chemistry ; Calorimetry, Differential Scanning ; Cross-Linking Reagents/chemistry ; Drug Liberation ; Gelatin/chemistry ; Gliclazide/administration & dosage ; Hydrogen-Ion Concentration ; Models, Chemical ; Particle Size ; Research Design ; Solubility ; Spectroscopy, Fourier Transform Infrared
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Bioequivalence of Two Formulations of Gliclazide in a Randomized Crossover Study in Healthy Caucasian Subjects Under Fasting Conditions.
Autorzy:
Pop DI; Department of Pharmaceutical Technology and Biopharmaceutics, Faculty of Pharmacy, University of Medicine and Pharmacy 'Iuliu Haţieganu,', Cluj-Napoca, Romania.; Clinical Pharmacology and Pharmacokinetics Department, Terapia S.A- a Sun Pharma Company, Cluj-Napoca, Romania.
Oroian M; Department of Pharmaceutical Technology and Biopharmaceutics, Faculty of Pharmacy, University of Medicine and Pharmacy 'Iuliu Haţieganu,', Cluj-Napoca, Romania.; Clinical Pharmacology and Pharmacokinetics Department, Terapia S.A- a Sun Pharma Company, Cluj-Napoca, Romania.
Bhardwaj S; Clinical Pharmacology and Pharmacokinetics Department, Terapia S.A- a Sun Pharma Company, Cluj-Napoca, Romania.
Marcovici A; Clinical Pharmacology and Pharmacokinetics Department, Terapia S.A- a Sun Pharma Company, Cluj-Napoca, Romania.
Khuroo A; Clinical Pharmacology and Pharmacokinetics Department, Gurugram, India.
Kochhar R; R&D Formulation Development, Gurugram, India.
Vlase L; Department of Pharmaceutical Technology and Biopharmaceutics, Faculty of Pharmacy, University of Medicine and Pharmacy 'Iuliu Haţieganu,', Cluj-Napoca, Romania.
Pokaż więcej
Źródło:
Clinical pharmacology in drug development [Clin Pharmacol Drug Dev] 2019 Jan; Vol. 8 (1), pp. 16-21. Date of Electronic Publication: 2018 Mar 26.
Typ publikacji:
Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms:
Gliclazide/*pharmacokinetics
Hypoglycemic Agents/*pharmacokinetics
Administration, Oral ; Adult ; Cross-Over Studies ; Drug Compounding ; Fasting/metabolism ; Female ; Gliclazide/administration & dosage ; Gliclazide/adverse effects ; Gliclazide/blood ; Healthy Volunteers ; Humans ; Hypoglycemic Agents/administration & dosage ; Hypoglycemic Agents/adverse effects ; Hypoglycemic Agents/blood ; Male ; Tablets ; Therapeutic Equivalency ; White People ; Young Adult
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
In vitro and in vivo delivery of gliclazide loaded mPEG-PCL micelles and its kinetic release and solubility study.
Autorzy:
Danafar H; a Zanjan Pharmaceutical Nanotechnology Research Center, Zanjan University of Medical Sciences , Zanjan , Iran.; b Department of Pharmaceutical Nanotechnology , School of Pharmacy, Zanjan University of Medical Sciences , Zanjan , Iran.
Jaberizadeh H; b Department of Pharmaceutical Nanotechnology , School of Pharmacy, Zanjan University of Medical Sciences , Zanjan , Iran.
Andalib S; c Department of Pharmacology and Toxicology , School of Pharmacy, Zanjan University of Medical Sciences , Zanjan , Iran.
Pokaż więcej
Źródło:
Artificial cells, nanomedicine, and biotechnology [Artif Cells Nanomed Biotechnol] 2018 Dec; Vol. 46 (8), pp. 1625-1636. Date of Electronic Publication: 2017 Nov 03.
Typ publikacji:
Journal Article
MeSH Terms:
Gliclazide*/pharmacokinetics
Gliclazide*/pharmacology
Diabetes Mellitus, Experimental/*drug therapy
Animals ; Delayed-Action Preparations/pharmacokinetics ; Delayed-Action Preparations/pharmacology ; Diabetes Mellitus, Experimental/metabolism ; Diabetes Mellitus, Experimental/pathology ; Male ; Micelles ; Rats ; Rats, Wistar ; Solubility
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 1731

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies